Thierry Langer Selected Research

Thierry Langer Research Topics

Disease

6	Neoplasms (Cancer) 10/2022 - 03/2003
5	Obesity 01/2018 - 06/2006
4	Breast Neoplasms (Breast Cancer) 01/2019 - 10/2005
4	Atherosclerosis 01/2018 - 08/2008
3	Body Weight (Weight, Body) 01/2017 - 03/2016
2	Hepatitis B 02/2023 - 11/2019
2	Neurodegenerative Diseases (Neurodegenerative Disease) 06/2021 - 12/2018
2	Infections 05/2020 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 10/2008
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2015 - 08/2005
2	Hypertension (High Blood Pressure) 06/2006 - 03/2006
1	Cognitive Dysfunction 11/2023
1	COVID-19 01/2023
1	Nervous System Diseases (Neurological Disorders) 05/2022
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2022
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Disease Progression 06/2021
1	Cocaine-Related Disorders (Cocaine Addiction) 01/2020
1	Seizures (Absence Seizure) 10/2019
1	Fatty Liver 01/2018
1	Virus Diseases (Viral Diseases) 06/2015
1	Osteoporosis 01/2009
1	Chronic Pain 01/2009
1	Respiratory Tract Diseases (Respiratory Tract Disease) 02/2008
1	Muscular Atrophy (Muscle Atrophy) 06/2006
1	Atherosclerotic Plaque (Atheroma) 03/2006
1	Lung Diseases (Lung Disease) 03/2006
1	Inflammation (Inflammations) 03/2004

Drug/Important Bio-Agent (IBA)

3	LigandsIBA 06/2015 - 10/2008
3	11-beta-Hydroxysteroid Dehydrogenase Type 1IBA 06/2006 - 08/2005
2	Modafinil (Provigil)FDA Link 11/2023 - 01/2020
2	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 05/2022 - 06/2021
2	VaccinesIBA 05/2020 - 01/2020
2	Antiviral Agents (Antivirals)IBA 01/2020 - 06/2015
2	EnzymesIBA 06/2006 - 03/2004
1	Dopamine (Intropin)FDA LinkGeneric 11/2023
1	Peptide Hydrolases (Proteases)FDA Link 02/2023
1	SulfonamidesIBA 01/2023
1	Chalcone (Benzalacetophenone)IBA 01/2023
1	Alkylating AgentsIBA 10/2022
1	aziridine (ethyleneimine)IBA 10/2022
1	Proteasome InhibitorsIBA 10/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	holothurin AIBA 01/2022
1	AndrogensIBA 01/2022
1	AntiemeticsIBA 01/2022
1	General AnestheticsIBA 01/2022
1	TriterpenesIBA 01/2022
1	Anti-Anxiety Agents (Anxiolytics)IBA 01/2022
1	SaponinsIBA 01/2022
1	Cholinergic Agents (Cholinergics)IBA 06/2021
1	Dopamine Uptake Inhibitors (Dopamine Reuptake Inhibitors)IBA 01/2020
1	benzothiopheneIBA 11/2019
1	Pentylenetetrazole (Metrazol)IBA 10/2019
1	Estrogen Receptor AntagonistsIBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Essential Amino AcidsIBA 12/2018
1	Large Neutral Amino Acid-Transporter 1IBA 12/2018
1	Proto-Oncogene Proteins c-fynIBA 12/2018
1	Eosinophil PeroxidaseIBA 12/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	GTP-Binding Proteins (G-Protein)IBA 01/2018
1	Estrogens (Estrogen)FDA Link 10/2017
1	Tamoxifen FDA LinkGeneric 10/2017
1	Estrogen ReceptorsIBA 10/2017
1	4- ((benzhydrylsulfinyl)methyl)- 2- cyclopropylthiazoleIBA 01/2017
1	CE-111IBA 10/2016
1	2-((benzhydrylsulfinyl)methyl)thiazoleIBA 03/2016
1	Benzoates (Benzoate)IBA 06/2009
1	Protein Tyrosine PhosphatasesIBA 06/2009
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2009
1	Glucose (Dextrose)FDA LinkGeneric 10/2008
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 10/2008
1	Cysteine Proteases (Cysteine Protease)IBA 08/2008
1	cathepsin SIBA 08/2008
1	Proteins (Proteins, Gene)FDA Link 02/2008
1	GlucocorticoidsIBA 06/2006
1	Gonadal Steroid Hormones (Sex Hormones)IBA 06/2006
1	SodiumIBA 06/2006
1	11-beta-Hydroxysteroid Dehydrogenase Type 2 (11 beta-Hydroxysteroid Dehydrogenase Type 2)IBA 06/2006
1	Aromatase (CYP19)IBA 05/2006
1	CholesterolIBA 03/2006
1	7-ketocholesterolIBA 03/2006
1	Metalloproteases (Metalloproteinases)IBA 03/2006
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2006
1	ChlorineIBA 10/2005
1	Hydrocortisone (Cortisol)FDA LinkGeneric 08/2005
1	Cortisone FDA Link 08/2005
1	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 03/2004
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2003

Therapy/Procedure

3	Therapeutics 01/2020 - 03/2003
1	Drug Therapy (Chemotherapy) 05/2020